Learn about CVE-2018-10634 involving Medtronic insulin pumps transmitting data without encryption, risking exposure of sensitive information. Find mitigation steps and prevention measures.
CVE-2018-10634 was published on August 8, 2018, by ICS-CERT. It involves the Medtronic insulin pump and its vulnerability to cleartext transmission of sensitive information.
Understanding CVE-2018-10634
This CVE highlights the risk of unauthorized interception of communication between specific Medtronic insulin pump models and their wireless accessories due to lack of encryption.
What is CVE-2018-10634?
The vulnerability in CVE-2018-10634 allows skilled attackers to capture unencrypted transmissions between Medtronic insulin pumps and wireless accessories, potentially exposing sensitive data like device serial numbers.
The Impact of CVE-2018-10634
The lack of encryption in communication poses a significant security risk as attackers could exploit this vulnerability to access confidential information, compromising patient privacy and device integrity.
Technical Details of CVE-2018-10634
This section delves into the specifics of the vulnerability.
Vulnerability Description
The Medtronic MMT 508 MiniMed insulin pump, along with other specified models, transmit data in cleartext, making it susceptible to interception by malicious actors.
Affected Systems and Versions
The affected products include the MMT 508 MiniMed insulin pump, 522 / MMT - 722 Paradigm REAL-TIME, 523 / MMT - 723 Paradigm Revel, 523K / MMT - 723K Paradigm Revel, and 551 / MMT - 751 MiniMed 530G.
Exploitation Mechanism
Attackers with the necessary skills can intercept wireless transmissions between the vulnerable Medtronic insulin pumps and their accessories to extract sensitive information.
Mitigation and Prevention
Protecting against CVE-2018-10634 requires immediate actions and long-term security measures.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates
Medtronic or relevant authorities may release patches or updates to address the vulnerability. Stay informed about these releases and apply them promptly.